Analysts recommend holding DuPont stock driven by innovation and strategic acquisitions in healthcare and water sectors. Despite construction headwinds and cost pressures, organic growth is anticipated from high-growth investments. The focus benefits specialty chemicals and industrial applications linked to EVs and water solutions. Traditional commodity segments face pressure from uneven construction demand and input cost volatility. DuPont plans pricing adjustments to offset higher oil and gas-related input costs. Productivity improvements aim to mitigate margin compression while sustaining profitability in Building Technologies.
81 articles
DuPont de Nemours shares rose after Q2 2026 earnings beat consensus with $1.88 EPS and 4% revenue growth. Positive dividend signals and analyst outlook drove investor confidence despite cyclical marke
DuPont stock is recommended for its focus on innovation and acquisitions in healthcare and water, despite challenges from construction demand and rising oil and gas input costs.
Corient Private Wealth LP reduced its stake in DuPont de Nemours by 66.8% in Q2 2026, despite the company reporting strong earnings of $1.88 EPS and announcing a $0.60 quarterly dividend.
DuPont de Nemours has launched Tyvek with Renewable Attribution, offering 30%–100% renewable content certified by ISCC PLUS. This drop-in solution supports customer ESG targets with up to 30% CO2 redu
Allworth Financial LP cut its DuPont de Nemours stake by 68.6% in Q2 to hold $789,000 worth of shares. Despite this reduction, other institutions increased positions, and analysts maintain a Moderate
Engineers Gate Manager LP reduced its DuPont stake by 55.6% in Q2, selling 35,053 shares. DuPont reported strong Q2 earnings of $1.88 per share, exceeding estimates with 4% revenue growth.
Chemours, DuPont, and Corteva agreed to a $455 million settlement with North Carolina communities regarding PFAS contamination leaks from Chemours' Fayetteville facility. Payments will be distributed
Sequoia Financial Advisors LLC reduced its DuPont stake by 64.2% to $45.07 million in Q2. DuPont reported strong quarterly earnings beating estimates, with analysts maintaining a Moderate Buy rating.
CalSTRS increased its DuPont de Nemours stake to 38 million shares valued at $5.24 billion in Q2, indicating strong institutional interest despite recent trading declines.
IFP Advisors Inc increased its stake in DuPont de Nemours by 28.2% in Q2, acquiring 26,882 shares valued at $16.6 million amid the company's strong quarterly earnings report.
Groupe La Française acquired 10,271 shares of DuPont de Nemours worth approximately $1.39 million in Q2, while analysts maintain a Moderate Buy rating with a $166.60 price target.
Allianz reduced its DuPont stake by 48% to $14.15 million, though other investors increased positions. DuPont beat earnings estimates and announced a $0.60 quarterly dividend.
Bank OZK reduced its stake in DuPont de Nemours by 64.6% in Q2, selling 19,727 shares. DuPont also reported strong quarterly earnings beating estimates and declared a $0.60 dividend.
Nykredit A/S invested $5.66 million in DuPont de Nemours, acquiring 41,702 shares in Q2, amidst broader institutional interest despite recent dividend cuts.
Ancora Advisors LLC reduced its stake in DuPont de Nemours by 66.6% in Q2, selling 122,220 shares. DuPont reported strong Q2 earnings of $1.88 per share, beating estimates with 4% revenue growth.
Ballast Inc. reduced its stake in DuPont de Nemours by 55.9% in Q2, selling 15,628 shares. DuPont reported strong quarterly earnings, beating estimates with $1.88 EPS and a 4% revenue increase.
The New Mexico Educational Retirement Board reduced its DuPont stake by 64.6% in Q2, while institutional ownership remains near 74%. DuPont exceeded earnings expectations with analysts maintaining a M
The Public Employees Retirement System of Ohio acquired 81,458 shares of DuPont de Nemours valued at $11.05 million. The company also reported strong quarterly earnings exceeding analyst estimates.
Clifford Swan Investment Counsel LLC cut its DuPont position by 68.3% to $8.7 million in Q2. DuPont reported strong quarterly earnings of $1.88 EPS and 4% revenue growth, maintaining a Moderate Buy ra
DuPont de Nemours received a "Moderate Buy" consensus from 17 brokerages with an average price target of $166.60. The company reported strong Q2 earnings beating estimates and announced a quarterly di
Ancora Advisors LLC purchased 61,316 shares of DuPont de Nemours valued at approximately $8.3 million in Q2, while analysts maintain a Moderate Buy consensus with a price target of $166.60.
Cullen Capital Management initiated a $2.08 million position in DuPont de Nemours during Q2. The company reported strong second-quarter earnings, beating estimates with $1.88 EPS and declaring a $0.60
DuPont stock remains stable ahead of earnings, navigating a $2.5 billion PFAS settlement and legal developments. The company focuses on advanced materials for automotive and electronics while managing
DuPont de Nemours Inc. shares advanced 1.50% to $146.26, outperforming the broader market and breaking a two-day losing streak during a session where major indices declined.
DuPont de Nemours Inc. disclosed its asset turnover metric on the Buenos Aires Stock Exchange (BCBA:DD.CI). This financial data point tracks the company's operational efficiency.
DuPont de Nemours filed a Form S-4 effective August 11, 2026, signaling potential corporate restructuring. The filing carries neutral sentiment with standard stock data updates included.
Shares of DuPont de Nemours Inc. rose 2.08% to $144.49, outperforming the broader market and ending a three-day losing streak.
DuPont VP Madeleine Barber had 100.8 shares withheld on August 6, 2026, to cover tax liabilities on RSUs. The transaction was valued at $146.375 per share.
DuPont de Nemours received a "Moderate Buy" consensus from 17 research firms with a $165.40 price target. The company recently reported strong quarterly earnings that beat estimates and announced a $0
DuPont de Nemours Inc. shares rose 3.11% to $147.37, outperforming the broader market for the third consecutive day amid mixed trading conditions.
ChemBrief